An international research collaborative has determined that a promising anti-malarial compound tricks the immune system to rapidly destroy red blood cells infected with the malaria parasite but leave healthy cells unharmed.
St. Jude Children’s Research Hospital scientists led the study, which appears in the current online early edition of the Proceedings of the National Academy of Sciences (PNAS).
The compound, (+)-SJ733, was developed from a molecule identified in a previous St. Jude-led study that helped to jumpstart worldwide anti-malarial drug development efforts. Malaria is caused by a parasite spread through the bite of an infected mosquito. The disease remains a major health threat to more than half the world’s population, particularly children. The World Health Organization estimates that in Africa a child dies of malaria every minute.
In this study, researchers determined that (+)-SJ733 uses a novel mechanism to kill the parasite by recruiting the immune system to eliminate malaria-infected red blood cells. In a mouse model of malaria, a single dose of (+)-SJ733 killed 80 percent of malaria parasites within 24 hours. After 48 hours the parasite was undetectable.
Planning has begun for safety trials of the compound in healthy adults.
Laboratory evidence suggests that the compound’s speed and mode of action work together to slow and suppress development of drug-resistant parasites. Drug resistance has long undermined efforts to treat and block malaria transmission.
“Our goal is to develop an affordable, fast-acting combination therapy that cures malaria with a single dose,” said corresponding author R. Kiplin Guy, Ph.D., chair of the St. Jude Department of Chemical Biology and Therapeutics. “These results indicate that SJ733 and other compounds that act in a similar fashion are highly attractive additions to the global malaria eradication campaign, which would mean so much for the world’s children, who are central to the mission of St. Jude.”
Whole genome sequencing of the Plasmodium falciparum, the deadliest of the malaria parasites, revealed that (+)-SJ733 disrupted activity of the ATP4 protein in the parasites. The protein functions as a pump that the parasites depend on to maintain the proper sodium balance by removing excess sodium.
The sequencing effort was led by co-author Joseph DeRisi, Ph.D., a Howard Hughes Medical Institute investigator and chair of the University of California, San Francisco Department of Biochemistry and Biophysics. Investigators used the laboratory technique to determine the makeup of the DNA molecule in different strains of the malaria parasite.
Researchers showed that inhibiting ATP4 triggered a series of changes in malaria-infected red blood cells that marked them for destruction by the immune system. The infected cells changed shape and shrank in size. They also became more rigid and exhibited other alterations typical of aging red blood cells. The immune system responded using the same mechanism the body relies on to rid itself of aging red blood cells.
Another promising class of antimalarial compounds triggered the same changes in red blood cells infected with the malaria parasite, researchers reported. The drugs, called spiroindolones, also target the ATP4 protein. The drugs include NITD246, which is already in clinical trials for treatment of malaria. Those trials involve investigators at other institutions.
“The data suggest that compounds targeting ATP4 induce physical changes in the infected red blood cells that allow the immune system or erythrocyte quality control mechanisms to recognize and rapidly eliminate infected cells,” DeRisi said. “This rapid clearance response depends on the presence of both the parasite and the investigational drug. That is important because it leaves uninfected red blood cells, also known as erythrocytes, unharmed.”
Laboratory evidence also suggests that the mechanism will slow and suppress development of drug-resistant strains of the parasite, researchers said.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- New malaria vaccine brings hope to sub-Saharan Africaon October 26, 2021 at 5:44 am
In early October, the World Health Organization endorsed widespread use of the first-ever vaccine against malaria, a parasitic disease transmitted by the bite of an infective female Anopheles mosquito ...
- High hopes for anti-malaria vaccineon October 25, 2021 at 11:33 pm
After testing on more than 800,000 children in Malawi, Ghana and Kenya, the WHO has recommended the use of a vaccine against malaria, a disease that kills nearly 400,000 people every year, mostly ...
- WHO recommends groundbreaking malaria vaccine for children at riskon October 25, 2021 at 1:43 pm
The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P.
- Activation of liver macrophages in murine malaria is enhanced by vaccination.on October 25, 2021 at 12:42 pm
During blood-stage infection of mice with a lethal variant of Plasmodium yoelii, cells in both spleen and liver became activated to reach a peak at day 5. In mice protected by vaccination, activation ...
- World’s Deadliest Malaria Parasite Dominance in Africa Could Be Over – Expertson October 25, 2021 at 2:13 am
One morning in 2016, Lillian Nekesa’s 3-year-old woke up with flu-like classic symptoms of malaria. This was not Kevin’s first encounter with the killer disease. Kevin was nonetheless not immediately ...
- U.S. should make new malaria vaccine widely availableon October 25, 2021 at 12:00 am
Early this month, there was a bit of international news that might have slipped past many readers, even as many of us in North Texas volunteer ...
- WHO Recommends First-Ever Malaria Vaccine For Babies & Toddlers In At Risk Regionson October 22, 2021 at 8:00 am
Babies who were physically unable to fight off malaria due to immature immune systems now will have an opportunity to grow into healthy adults.
- Broad-spectrum malaria vaccine developedon October 21, 2021 at 5:07 am
Griffith University researchers are a step closer in the fight against malaria with the development of a broad-spectrum vaccine that can be freeze-dried making it suitable for deployment into ...
- Eradication of Malaria Is Within Reachon October 19, 2021 at 9:01 am
It is now possible to conceptualize in our lifetime the eradication of malaria. That's because the World Health Organization (WHO) is " recommending widespread use of the RTS,S/AS01 (RTS,S) malaria ...
- Historic yet imperfect: Malaria vaccine brings hope but the fight is far from overon October 17, 2021 at 5:49 am
The WHO's endorsement of a malaria vaccine is a huge step forward. But it isn't a silver bullet against a disease that affects millions.
via Bing News